Geneos Wealth Management’s Avantis US Large Cap Value ETF AVLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$115K Sell
1,261
-14
-1% -$1.23K ﹤0.01% 1167
2026
Q1
$103K Buy
1,275
+35
+3% +$2.84K ﹤0.01% 1159
2025
Q4
$94K Hold
1,240
– – ﹤0.01% 1164
2025
Q3
$89.6K Hold
1,240
– – ﹤0.01% 1161
2025
Q2
$84.6K Buy
1,240
+620
+100% +$39.9K ﹤0.01% 1318
2025
Q1
$40.4K Hold
620
– – ﹤0.01% 1599
2024
Q4
$41.4K Buy
620
+220
+55% +$15K ﹤0.01% 1392
2024
Q3
$26.3K Buy
400
+156
+64% +$9.93K ﹤0.01% 1449
2024
Q2
$15.3K Buy
+244
New +$15.3K ﹤0.01% 1424

Other funds holding AVLV

Geneos Wealth Management's AVLV Position: Q2 2026 in Review

Geneos Wealth Management reduced its Avantis US Large Cap Value ETF (AVLV) stake by 1.1% in Q2 2026, selling an estimated $1.23K and leaving 1,261 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #1167.

Geneos Wealth Management first reported a position in AVLV in Q2 2024 and has held it in 9 quarters since. 566 funds tracked by Wall St. Rank hold AVLV as of Q2 2026.

  • Geneos Wealth Management held 1,261 shares of Avantis US Large Cap Value ETF worth $115K as of Q2 2026.
  • Geneos Wealth Management sold 14 Avantis US Large Cap Value ETF shares in Q2 2026, an estimated $1.23K.
  • Avantis US Large Cap Value ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1167 holding.
  • Geneos Wealth Management first reported a position in Avantis US Large Cap Value ETF in Q2 2024 and has held it in 9 quarters since.
  • 566 funds tracked by Wall St. Rank held Avantis US Large Cap Value ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.